Skip to main content
Top
Published in: International Urology and Nephrology 10/2017

01-10-2017 | Urology - Original Paper

An initial differential renal function between 35% and 40% has greater probability of leading to normal after pyeloplasty in patients with unilateral pelvic-ureteric junction obstruction

Authors: Guofeng Xu, Maosheng Xu, Jianqi Ma, Zhoutong Chen, Dapeng Jiang, Zhihua Hong, Houwei Lin, Xiaoliang Fang, Liguo Wang, Lei He, Hongquan Geng

Published in: International Urology and Nephrology | Issue 10/2017

Login to get access

Abstract

Purpose

We compared the outcomes in patients who were <1 year old and had hydronephrosis with SFU grade 3–4 PUJ obstruction to observe the potential recovery of renal morphology and DRF after successful pyeloplasty.

Methods

All children younger than 1 year old with SFU grade 3–4 PUJ obstruction from January 2013 to June 2015 were retrospectively analyzed. A total of 92 children were grouped according to their DRF value at pyeloplasty as follows: DRF from 30 to ≤35% (group I) and DRF from 35 to ≤40% (group II). We evaluated changes in anteroposterior diameter and differential renal function using ultrasound and diuretic renography. Outcomes were compared using Student t test.

Results

Group I comprised 45 patients, and group II included 47 patients. No significant difference was observed in the initial APD, final APD and the improvement of APD after pyeloplasty between two groups. Significant differences were observed between the initial and final DRF values in both groups. The difference in DRF improvement after pyeloplasty between groups I and II was significant. The DRF improved to a normal stage significantly more frequently in group II (21/47; 44.7%) than in group I (13/45; 28.9%).

Conclusion

The improvement in DRF after pyeloplasty was significant for patients with an initial DRF from 30 to ≤35%. However, patients with an initial DRF from 35 to ≤40% had a greater probability of achieving normal renal function. Patients with severely impaired initial renal function had a marginal probability of achieving a normal value.
Literature
1.
go back to reference Blyth B, Snyder HM, Duckett JW (1993) Antenatal diagnosis and subsequent management of hydronephrosis. J Urol 149:693–698CrossRefPubMed Blyth B, Snyder HM, Duckett JW (1993) Antenatal diagnosis and subsequent management of hydronephrosis. J Urol 149:693–698CrossRefPubMed
2.
go back to reference Ulman I, Jayanthi VR, Koff SA (2000) The long-term followup of newborns with severe unilateral hydronephrosis initially treated nonoperatively. J Urol 164:1101–1105CrossRefPubMed Ulman I, Jayanthi VR, Koff SA (2000) The long-term followup of newborns with severe unilateral hydronephrosis initially treated nonoperatively. J Urol 164:1101–1105CrossRefPubMed
3.
go back to reference Maizels M, Mitchell B, Kass E et al (1994) Outcome of nonspecific hydronephrosis in the infant: a report from the registry of the Society for Fetal Urology. J Urol 152:2324–2327CrossRefPubMed Maizels M, Mitchell B, Kass E et al (1994) Outcome of nonspecific hydronephrosis in the infant: a report from the registry of the Society for Fetal Urology. J Urol 152:2324–2327CrossRefPubMed
4.
go back to reference Palmer LS, Maizels M, Cartwright PC et al (1998) Surgical versus observation for managing obstructive grade 3 to 4 unilateral hydronephrosis: a report from the Society for Fetal Urology. J Urol 159:222–228CrossRefPubMed Palmer LS, Maizels M, Cartwright PC et al (1998) Surgical versus observation for managing obstructive grade 3 to 4 unilateral hydronephrosis: a report from the Society for Fetal Urology. J Urol 159:222–228CrossRefPubMed
5.
go back to reference Riedmiller H, Androulakakis P, Beurton D et al (2001) EAU guidelines on paediatric urology. Eur Urol 40:589–599CrossRefPubMed Riedmiller H, Androulakakis P, Beurton D et al (2001) EAU guidelines on paediatric urology. Eur Urol 40:589–599CrossRefPubMed
6.
go back to reference Sinha A, Bagga A, Krishna A et al (2013) Revised guidelines on management of antenatal hydronephrosis. Indian Pediatr 50:215–231CrossRefPubMed Sinha A, Bagga A, Krishna A et al (2013) Revised guidelines on management of antenatal hydronephrosis. Indian Pediatr 50:215–231CrossRefPubMed
7.
go back to reference Nguyen HT, Herndon CD, Cooper C et al (2010) The Society for Fetal Urology consensus statement on the evaluation and management of antenatal hydronephrosis. J Pediatr Urol 6(3):212–231CrossRefPubMed Nguyen HT, Herndon CD, Cooper C et al (2010) The Society for Fetal Urology consensus statement on the evaluation and management of antenatal hydronephrosis. J Pediatr Urol 6(3):212–231CrossRefPubMed
8.
go back to reference Jiang D, Tang B, Xu M et al (2016) Functional and morphological outcomes of pyeloplasty at different ages in prenatally diagnosed Society of Fetal Urology grades 3-4 ureteropelvic junction obstruction: is it safe to wait? Urology 101:45–49CrossRefPubMed Jiang D, Tang B, Xu M et al (2016) Functional and morphological outcomes of pyeloplasty at different ages in prenatally diagnosed Society of Fetal Urology grades 3-4 ureteropelvic junction obstruction: is it safe to wait? Urology 101:45–49CrossRefPubMed
9.
go back to reference Merguerian PA, Herz D, McQuiston L et al (2010) Variation among pediatric urologists and across 2 continents in antibiotic prophylaxis and evaluation for prenatally detected hydronephrosis: a survey of American and European pediatric urologists. J Urol 184:1710–1715CrossRefPubMed Merguerian PA, Herz D, McQuiston L et al (2010) Variation among pediatric urologists and across 2 continents in antibiotic prophylaxis and evaluation for prenatally detected hydronephrosis: a survey of American and European pediatric urologists. J Urol 184:1710–1715CrossRefPubMed
10.
go back to reference Von Rundstedt FC, Scovell JM, Bian SX et al (2017) Percent of tracer clearance at 40 minutes in MAG3 renal scans is more sensitive than T1/2 for symptomatic ureteropelvic junction obstruction. Urology 103:245–250CrossRef Von Rundstedt FC, Scovell JM, Bian SX et al (2017) Percent of tracer clearance at 40 minutes in MAG3 renal scans is more sensitive than T1/2 for symptomatic ureteropelvic junction obstruction. Urology 103:245–250CrossRef
11.
go back to reference Prigent A, Cosgriff P, Gates GF et al (1999) Consensus report on quality control of quantitative measurements of renal function obtained from renogram: International Consensus Committee from the Scientific Committee of Radionuclides in Nephrourology. Semin Nucl Med 29:146–159CrossRefPubMed Prigent A, Cosgriff P, Gates GF et al (1999) Consensus report on quality control of quantitative measurements of renal function obtained from renogram: International Consensus Committee from the Scientific Committee of Radionuclides in Nephrourology. Semin Nucl Med 29:146–159CrossRefPubMed
12.
go back to reference Eskild-Jensen A, Gordon I, Piepsz A et al (2004) Interpretation of the renogram: problems and pitfalls in hydronephrosis in children. BJU Int 94:887–892CrossRefPubMed Eskild-Jensen A, Gordon I, Piepsz A et al (2004) Interpretation of the renogram: problems and pitfalls in hydronephrosis in children. BJU Int 94:887–892CrossRefPubMed
13.
go back to reference Chertin B, Rolle U, Farkas A et al (2002) Does delaying pyeloplasty affect renal function in children with a prenatal diagnosis of pelviureteric junction obstruction? BJU Int 90:72–75CrossRefPubMed Chertin B, Rolle U, Farkas A et al (2002) Does delaying pyeloplasty affect renal function in children with a prenatal diagnosis of pelviureteric junction obstruction? BJU Int 90:72–75CrossRefPubMed
14.
go back to reference Karnak I, Woo LL, Shah SN et al (2009) Results of a practical protocol for management of prenatally detected hydronephrosis due to ureteropelvic junction obstruction. Pediatr Surg Int 25:61–67CrossRefPubMed Karnak I, Woo LL, Shah SN et al (2009) Results of a practical protocol for management of prenatally detected hydronephrosis due to ureteropelvic junction obstruction. Pediatr Surg Int 25:61–67CrossRefPubMed
15.
go back to reference Jain V, Agarwala S, Bhatnagar V et al (2012) Long term outcome of management of antenatally diagnosed pelvi-ureteric junction obstruction. Indian J Pediatr 79:769–773CrossRefPubMed Jain V, Agarwala S, Bhatnagar V et al (2012) Long term outcome of management of antenatally diagnosed pelvi-ureteric junction obstruction. Indian J Pediatr 79:769–773CrossRefPubMed
16.
go back to reference Subramaniam R, Kouriefs C, Dickson AP (1999) Antenatally detected pelvi-ureteric junction obstruction: concerns about conservative management. BJU Int 84:335–338CrossRefPubMed Subramaniam R, Kouriefs C, Dickson AP (1999) Antenatally detected pelvi-ureteric junction obstruction: concerns about conservative management. BJU Int 84:335–338CrossRefPubMed
17.
go back to reference Cornford PA, Rickwood AM (1998) Functional results of pyeloplasty in patients with ante-natally diagnosed pelvi-ureteric junction obstruction. Br J Urol 81:152–155CrossRefPubMed Cornford PA, Rickwood AM (1998) Functional results of pyeloplasty in patients with ante-natally diagnosed pelvi-ureteric junction obstruction. Br J Urol 81:152–155CrossRefPubMed
18.
go back to reference Vemulakonda VM, Wilcox DT, Crombleholme TM et al (2015) Factors associated with age at pyeloplasty in children with ureteropelvic junction obstruction. Pediatr Surg Int 31:871–877CrossRefPubMed Vemulakonda VM, Wilcox DT, Crombleholme TM et al (2015) Factors associated with age at pyeloplasty in children with ureteropelvic junction obstruction. Pediatr Surg Int 31:871–877CrossRefPubMed
19.
go back to reference Kim SO, Yu HS, Hwang IS et al (2014) Early pyeloplasty for recovery of parenchymal thickness in children with unilateral ureteropelvic junction obstruction. Urol Int 92:473–476CrossRefPubMed Kim SO, Yu HS, Hwang IS et al (2014) Early pyeloplasty for recovery of parenchymal thickness in children with unilateral ureteropelvic junction obstruction. Urol Int 92:473–476CrossRefPubMed
20.
go back to reference Chandrasekharam VV, Srinivas M, Bal CS (2001) Functional outcome after pyeloplasty for unilateral symptomatic hydronephrosis. Pediatr Surg Int 17:524–527CrossRefPubMed Chandrasekharam VV, Srinivas M, Bal CS (2001) Functional outcome after pyeloplasty for unilateral symptomatic hydronephrosis. Pediatr Surg Int 17:524–527CrossRefPubMed
21.
go back to reference Koff SA, Campbell KD (1994) The nonoperative management of unilateral neonatal hydronephrosis: natural history of poorly functioning kidneys. J Urol 152:593–595CrossRefPubMed Koff SA, Campbell KD (1994) The nonoperative management of unilateral neonatal hydronephrosis: natural history of poorly functioning kidneys. J Urol 152:593–595CrossRefPubMed
22.
go back to reference Shokeir AA, El-Sherbiny MT, Gad HM et al (2005) Postnatal unilateral pelviureteral junction obstruction: impact of pyeloplasty and conservative management on renal function. Urology 65:980–985CrossRefPubMed Shokeir AA, El-Sherbiny MT, Gad HM et al (2005) Postnatal unilateral pelviureteral junction obstruction: impact of pyeloplasty and conservative management on renal function. Urology 65:980–985CrossRefPubMed
24.
go back to reference Chertin B, Pollack A, Koulikov D et al (2006) Conservative treatment of ureteropelvic junction obstruction in children with antenatal diagnosis of hydronephrosis: lessons learned after 16 years of follow-up. Eur Urol 49:734–738CrossRefPubMed Chertin B, Pollack A, Koulikov D et al (2006) Conservative treatment of ureteropelvic junction obstruction in children with antenatal diagnosis of hydronephrosis: lessons learned after 16 years of follow-up. Eur Urol 49:734–738CrossRefPubMed
Metadata
Title
An initial differential renal function between 35% and 40% has greater probability of leading to normal after pyeloplasty in patients with unilateral pelvic-ureteric junction obstruction
Authors
Guofeng Xu
Maosheng Xu
Jianqi Ma
Zhoutong Chen
Dapeng Jiang
Zhihua Hong
Houwei Lin
Xiaoliang Fang
Liguo Wang
Lei He
Hongquan Geng
Publication date
01-10-2017
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 10/2017
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-017-1665-0

Other articles of this Issue 10/2017

International Urology and Nephrology 10/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.